197 related articles for article (PubMed ID: 1832993)
1. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
[TBL] [Abstract][Full Text] [Related]
2. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells.
Schwinzer R; Schlitt HJ; Wonigeit K
Cell Immunol; 1992 Mar; 140(1):31-41. PubMed ID: 1531453
[TBL] [Abstract][Full Text] [Related]
4. CD3 pathway of T-cell activation. II. Role of HLA-class I molecules in early events.
Schwab R; Weksler ME; Russo C
Cell Immunol; 1988 Sep; 115(2):310-24. PubMed ID: 2457448
[TBL] [Abstract][Full Text] [Related]
5. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
6. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
Oshima S; Eckels DD
J Immunol; 1990 Dec; 145(12):4018-25. PubMed ID: 1979584
[TBL] [Abstract][Full Text] [Related]
7. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
Wang H; Daniel V; Sadeghi M; Opelz G
Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
9. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
10. Regulation of expression of interleukin 2 receptors upon triggering of the TCR-CD3 complex on human T lymphocytes.
Kabouridis PS; Tsoukas CD
Immunol Invest; 1990 Aug; 19(4):385-401. PubMed ID: 2145219
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
[TBL] [Abstract][Full Text] [Related]
12. Immobilized anti-CD3-induced T cell growth: comparison of the frequency of responding cells within various T cell subsets.
Geppert TD; Lipsky PE
Cell Immunol; 1991 Mar; 133(1):206-18. PubMed ID: 1703926
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of aggregating the CD3 molecular complex on T cell activation.
Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE
Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456
[TBL] [Abstract][Full Text] [Related]
14. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
15. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
16. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of CD7+, CD3+, and CD8+ lymphocytes from first trimester human decidua using two-color flow cytometry.
Chernyshov VP; Slukvin II; Bondarenko GI
Am J Reprod Immunol; 1993 Jan; 29(1):5-16. PubMed ID: 7684920
[TBL] [Abstract][Full Text] [Related]
18. Regulation of thymocyte proliferation by alpha beta TcR+ CD3+ CD4- CD8- cloned natural suppressor (NS) cells.
Van Vlasselaer P; Fischer M; Strober S; Zlotnik A
Cell Immunol; 1991 Aug; 136(1):1-15. PubMed ID: 1829396
[TBL] [Abstract][Full Text] [Related]
19. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
[TBL] [Abstract][Full Text] [Related]
20. Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice.
Hertogh-Huijbregts A; Vissinga C; Rozing J; Nagelkerken L
Mech Ageing Dev; 1990 Apr; 53(2):141-55. PubMed ID: 1971316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
